The effect of wet-cupping on amenorrhea and oligomenorrhea

Not Applicable

• Conditions: Condition 1: Pcos. Condition 2: Ovarian dysfunction.; Polycystic ovarian syndrome; Ovarian dysfunction, unspecified

• Registration Number: IRCT2016062728664N1
• Lead Sponsor: Vice chancellor for research of Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 75

Inclusion Criteria

20-40 years old women with minimum 60 days menstruation retardation (from LMP); personal satisfaction; Not metformin or hormonal drugs users.
Exclusion criteria:
Use of hormonal or herbal drugs that affect menstruation; Positive BhcG; Lactation; Plannig to be pregnant during the next 3 months; History of thyroid dysfunction; History of anemia; History of coagulation diseases; History of diabetes mellitus; FSH >40; Hyperprolactinemia

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Menstrual blood volume. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.;Occurance of Menstrual bleeding. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient.;Duration of menstural bleeding. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.

Secondary Outcome Measures

Name	Time	Method
SHBG. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: SHBG serum assay.;Testosteron. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Serum testosteron assay.;Insulin resistance. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Fasting blood suger &insulin assay.;Quality of life. Timepoint: Before intervention and 4&12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.